A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity
- 1 March 1991
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 32 (3-4) , 312-320
- https://doi.org/10.1007/bf01980892
Abstract
Intraperitoneal and intra-articular (knee joint) injection of zymosan in the rat caused two phases of increased vascular permeability, a rapid increase (0.25–0.5 h) and a secondary increase (2–3 h) which was temporally associated with the onset of leukocyte infiltration. Intraperitoneal injection of zymosan led to a single peak of eicosanoid production (LTB4, C4, D4, E4 and 6-oxo-PGF1α ) which was maximal at 0.125–0.25 h. Intra-articular injection led to an initial peak of LTB4 production (maximal at 0.25 h) and a secondary peak of LTB4 and PGE2 production (maximal at 3 h). Oral administration of the 5-lipoxygenase (5-LO_ inhibitors phenidone, BW A4C (N-hydroxy-N-[3-(3-phenoxyphenyl)-2-propenyl] acetamide), A63162 (N-hydroxy-N-[1-(4-(phenylmethoxy) phenyl)ethyl] acetamide and ICI 207 968 (2-[3-pyridylmethyl]-indazolinone inhibited LTB4 production in A23187 stimulation bloodex vivo. The glucocorticosteroid dexamethasone had no effect in this model. The initial phase of increased vascular permeability in the peritoneal cavity and LTB4 production was dose dependently inhibited by the 5-LO inhibitors phenidone, BW A4C, A63162, and ICI 207 968 but not by dexamethasone or colchicine. The initial phase of increased permeability in the joint was unaffected by phenidone, BW A4C, dexamethasone or colchicine. However the latter two drugs inhibited the later phase of increased permeability and leukocyte infiltration in the joint and peritoneal cavity. These results demonstrate that zymosan induces eicosanoid productionin vivo but the relative importance of these mediators varies depending on the inflammatory site. Dexamethasone had a similar profile of anti-inflammatory activity to colchicine suggesting that inhibition of cell infiltration is the major mechanism of its therapeutic effect. No evidence for dexamethasone induced inhibition of eicosanoid production could be found suggesting that inhibition of the production or activity of other mediators is more important.Keywords
This publication has 20 references indexed in Scilit:
- In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenaseJournal of Medicinal Chemistry, 1987
- Kinetics of the generation and action of chemical mediators in zymosan‐induced inflammation of the rabbit peritoneal cavityBritish Journal of Pharmacology, 1986
- A comparison of the acute inflammatory response in adrenalectomised and sham‐operated ratsBritish Journal of Pharmacology, 1986
- Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2Prostaglandins, 1985
- Analysis of the Factor(s) Involved in Pathogenesis of Zymosan-Induced Inflammation in RatsThe Japanese Journal of Pharmacology, 1985
- Human 5-lipoxygenase: Measurement by radioimmunoassay of LTB4 in calcium ionophore stimulated bloodProstaglandins, 1984
- The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammationJournal of Pharmacy and Pharmacology, 1983
- Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay.The Journal of Experimental Medicine, 1983
- Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a.The Journal of Experimental Medicine, 1981
- Zymosan—Induced ArthritisArthritis & Rheumatism, 1977